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Abstract: 
 
The inositol 1,4,5-trisphosphate receptors (IP3Rs) and intracellular Ca
2+
 signaling are 
critically involved in regulating different steps of autophagy, a lysosomal degradation 
pathway. The ryanodine receptors (RyR), intracellular Ca
2+
-release channels mainly 
expressed in excitable cell types including muscle and neurons, have however not yet been 
extensively studied in relation to autophagy. Yet, aberrant expression and excessive activity 
of RyRs in these tissues has been implicated in the onset of several diseases including 
Alzheimer’s disease, where impaired autophagy regulation contributes to the pathology. In 
this study, we determined whether pharmacological RyR inhibition could modulate 
autophagic flux in ectopic RyR-expressing models, like HEK293 cells and in cell types that 
endogenously express RyRs, like C2C12 myoblasts and primary hippocampal neurons. 
Importantly, RyR3 overexpression in HEK293 cells impaired the autophagic flux. 
Conversely, in all cell models tested, pharmacological inhibition of endogenous or 
ectopically expressed RyRs, using dantrolene or ryanodine, augmented autophagic flux by 
increasing lysosomal turn-over (number of autophagosomes and autolysosomes measured as 
mCherry-LC3 punctae/cell increased from 70.37 ± 7.81 in control HEK RyR3 cells to 111.18 
± 7.72 and  98.14 ± 7.31 after dantrolene and ryanodine treatments, respectively). Moreover, 
in differentiated C2C12 cells, transmission electron microscopy demonstrated that dantrolene 
treatment decreased the number of early autophagic vacuoles from 5.9 ± 2.97 to 1.8 ± 1.03 
per cellular cross section. The modulation of the autophagic flux could be linked to the 
functional inhibition of RyR channels as both RyR inhibitors efficiently diminished the 
number of cells showing spontaneous RyR3 activity in the HEK293 cell model (from 41.14% 
± 2.12  in control cells to 18.70% ± 2.25 and 9.74 % ± 2.67  after dantrolene and ryanodine 
  
treatments, respectively). In conclusion, basal RyR-mediated Ca
2+
-release events suppress 
autophagic flux at the level of the lysosomes.  
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1. Introduction 
 
Autophagy, a lysosomal degradation pathway, is controlled by intracellular Ca
2+
 signals 
arising from different organelles, including the endoplasmic reticulum (ER) and lysosomes. 
(1-3) At the ER, inositol 1,4,5-trisphosphate (IP3) receptors (IP3R), IP3-gated intracellular 
Ca
2+
-release channels, are well-known regulators of autophagy. (4-7)  IP3Rs have been 
described to be involved in both inhibitory and stimulatory effects on autophagy. For 
instance, it has been shown that a continuous IP3R-mediated Ca
2+
 transfer from the ER to the 
mitochondrial matrix is necessary for proper energy production via mitochondrial respiration. 
Inhibition of IP3Rs, and thereby preventing the ER-to-mitochondrial Ca
2+
 transfer, results in 
the activation of the AMP-activated protein kinase (AMPK) resulting in the induction of 
autophagy. (8) IP3Rs also scaffold Beclin 1, an essential protein for phagophore formation, 
inhibiting autophagic flux by limiting Beclin 1 availability for Vps34-complex formation. (9) 
In contrast to these inhibitory actions, cytosolic Ca
2+
 elevations mediated by IP3Rs can also 
drive autophagy by activation of the calmodulin-dependent protein kinase kinase-β, an 
upstream activator of AMPK. (10) Moreover, starvation- and rapamycin-induced autophagic 
flux depends on IP3R-mediated Ca
2+
 signaling during which IP3Rs become sensitized by 
Beclin 1. (4,11) Lysosomal fusion events and other lysosomal functions, involved in 
autophagy, are also closely regulated by Ca
2+
. (12) Although Ca
2+
 is necessary for vesicle 
fusion, lysosomal Ca
2+
 release mediated by two pore channel 2 (TPC2) was also shown to 
inhibit the fusion of autophagosomes and lysosomes by increasing lysosomal pH. (13,14) 
 
In contrast to IP3Rs, ryanodine receptors (RyR), another class of ER-located intracellular 
Ca
2+
-release channels, have not been extensively studied with regards to autophagy 
  
regulation. RyRs are more restricted in their expression pattern compared to IP3Rs, which are 
expressed ubiquitously. High levels of RyRs can be found in skeletal muscle (mainly RyR 
isoform 1), the heart (mainly RyR isoform 2) and the brain (mainly RyR isoforms 2 and 3). 
(15) Aberrant RyR-mediated Ca
2+
 release has been associated with several diseases like 
malignant hyperthermia, (16) heart failure (17) and neurodegenerative diseases such as 
Huntington’s disease (HD) (18) and Alzheimer’s disease (AD). (19) These neurodegenerative 
diseases are characterized by the occurrence of protein aggregates (amyloid β in AD and 
mutant huntingtin in HD), which interfere with normal neuronal functioning. One way to 
clear protein aggregates is via the induction of autophagy. (20) Compounds that block 
voltage-gated Ca
2+
 channels have already been shown to have beneficial effects in HD 
models through the stimulation of autophagy. (21) Importantly, RyR inhibition via 
dantrolene, a clinically-approved drug used for treating malignant hyperthermia, (22) was 
able to reduce the occurrence of these protein aggregates. (18,23-25) Two studies indicate a 
potential role for RyRs in autophagy regulation. First, RyRs were shown to contribute to 
autophagic cell death in neuronal hippocampal stem cells. (26) Second, it was reported that in 
a mouse model of neuropathic Gaucher disease RyR inhibition, using dantrolene, delayed the 
neurological pathology and increased survival. (27) The authors reported that dantrolene 
could partially reverse the observed alterations in autophagic flux, suggesting a possible role 
for RyRs in regulating autophagy. However, it was not further studied how RyRs influenced 
autophagy.  
 
Here, we set out to identify whether modulating RyR activity can regulate autophagy, and if 
so, at which phase of the autophagic pathway this regulation occurs (proximal or more distal 
phases of the autophagic process). Using a HEK293 cell model overexpressing RyR3 (HEK 
RyR3), we first show that RyR3 overexpression impairs autophagic flux. Chemical RyR 
  
inhibition using dantrolene and ryanodine reversed this phenomenon and increased the 
autophagic flux at the level of the lysosomes without altering the activity of upstream 
autophagy regulators like AMPK and mTOR or the Beclin 1-expression level. Moreover, in 
HEK RyR3 cells, these inhibitors efficiently suppressed spontaneous Ca
2+
-release events. 
These findings were supported by experiments performed in differentiated C2C12 cells and 
in primary dissociated hippocampal neurons, two cell types that express endogenous RyRs. 
(27) Hence, these results indicate that RyR-mediated Ca
2+
-release events suppresses 
autophagic flux at steps distal to the initiation of phagophore formation, and involving 
alteration in lysosomal function   
  
2. Materials and methods 
 
2.1 Antibodies and reagents 
  
The antibodies used in this study were mouse anti-RyR clone 34C (Thermo Fisher Scientific, 
Ghent, Belgium), mouse anti-γ-tubulin (Sigma-Aldrich, Overijse, Belgium), mouse anti-
GAPDH (Sigma-Aldrich), mouse anti-LC3 antibody clone 5F10 (Nanotools, Teningen, 
Germany), mouse anti-actin (Sigma-Aldrich), mouse anti-Beclin 1 clone E8 (Santa Cruz, 
Dallas, USA), rabbit anti-S6 ribosomal clone 5G10, rabbit anti-phospho S6 ribosomal protein 
(Ser235/236), rabbit anti-AMPKα and rabbit anti-phospho-AMPKα clone 40H9 (Thr172) all 
from Cell Signaling Technology (Leiden, the Netherlands). Unless otherwise specified, 
chemicals were purchased from Sigma-Aldrich. Dantrolene was freshly prepared on the day 
of the experiment in water (warmed to 37°C) (1 mM stock) and filter sterilized. Dantrolene is 
a potent inhibitor of especially RyR1 and RyR3. In cell cultures, 10 to 50 µM of dantrolene is 
a common range of concentrations used in order to assure blocking of RyRs(24,28). We 
therefore selected 10 µM as working concentration. In the hippocampal neurons mainly 
RyR3, but also RyR2, is expressed.(29) As the RyR2 isoform is less sensitive to 
dantrolene(30) a higher  concentration (20 µM) was also included in these experiments in 
order to validate the effects of dantrolene. Bafilomycin A1 (Santa Cruz) and ryanodine (Enzo 
Life Sciences, Brussels, Belgium) were dissolved in DMSO. Bafilomycin A1 (100 nM) is 
commonly used to study autophagy, as at this concentration it is well known to potently block 
the V-type ATP-ases in the lysosomes, and thus to inhibit autophagic flux.(31) Ryanodine 
has a bimodal effect on the RyR, where low concentrations (nanomolar range) lock the 
channel in an open sub-conductance state, while high concentrations (micromolar range) 
  
inhibit RyR-mediated Ca
2+
 release.(32,33) The ryanodine concentration (20 µM) used in this 
study has been used in many studies to fully inhibit RyR activity.  
 
2.2 Cell culture and treatments lysate preparation 
 
Unless otherwise specified all cell culture media and supplements were obtained from 
Thermo Fisher Scientific. Cell lines were at least monthly checked for mycoplasma 
infections. Cell lines were passaged no more than 20 times before thawing fresh batches. All 
experiments were performed in mycoplasma-free cells. C2C12 cells were obtained from the 
ATCC (Molsheim Cedex, France) and were maintained and grown in growth medium 
(Dulbecco’s modified eagle medium (DMEM) supplemented with 10% fetal calf serum, 1% 
non-essential amino acids (NEAA), 100 IU/ml penicillin, 100 μg/ml streptomycin, 2 mM 
Glutamax and 0.5% chicken embryo extract (Biotrend, Köln, Germany). Differentiation of 
C2C12 cells was started by changing to differentiation medium (DMEM with 1% NEAA, 
100 IU/ml penicillin, 100 μg/ml streptomycin, 2 mM Glutamax, 1% horse serum and 0.5% 
insulin-transferrin-sodium selenite) when cells reached approximately 80% confluence. 
HEK293 cells were obtained from DSMZ (Braunschweig, Germany). The HEK RyR3 cells 
were a kind gift of Dr. Vincenzo Sorrentino. (34) HEK293 cells stably expressing either the 
empty pcDNA3.1(-) vector (HEK control), or this vector containing RyR3 (HEK RyR3) were 
cultured as described previously. (35) All cells were treated in the same manner. One day 
before the experiment the medium was changed. On the day of the experiment, the medium 
was also replaced. Two hours later, cells were treated with vehicle or the indicated 
concentrations of dantrolene or ryanodine in fresh medium. When dantrolene and ryanodine 
were used in the same experiment, DMSO was also added to the dantrolene treatment in 
  
order to be able to compare the treatments. Treatments lasted for three hours, and when 
indicated bafilomycin A1 (100 nM) was added for the final hour before harvesting the cells 
for analysis. After the treatments, cells were washed with phosphate-buffered saline (PBS) 
(Life Technologies), scraped and centrifuged at 500 x g. Pellets were solubilized in a 
CHAPS-based lysis buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 2 mM EDTA, 50 mM 
NaF (S7920), 1 mM Na3VO4, 1% CHAPS and protease inhibitor tablets (Roche, Basel, 
Switzerland) for 30 min at 4°C. After centrifuging at 4000 x g the supernatant was collected 
and used for immunoblot analysis. (35)  
 
2.3 Culture and treatment of dissociated hippocampal neurons  
 
Dissociated rat hippocampal neurons were obtained according to ethically approved 
guidelines and maintained as previously reported. (35) After fifteen days of culturing the 
dissociated hippocampal neurons, half of the medium was exchanged for fresh medium 
(neurobasal medium  containing 2 mM Glutamax, 100 IU/ml penicillin, 100 µg/ml 
streptomycin  and 2% B27 supplement, all from Life Technologies). Two hours later, half of 
the medium was taken from the neuronal cultures and was used to prepare experimental 
conditions as indicated in the text. Re-addition of this medium resulted in the final 
concentrations of vehicle, dantrolene and ryanodine. Three hours later, cells were harvested. 
When indicated bafilomycin A1 (100 nM) was added the last hour before harvesting the cells.  
 
 
 
  
2.4 mCherry-LC3 puncta and quantification 
 
HEK RyR3 cells were seeded in two-chamber slides and transfected two days later with 
pcDNA3.1(-) vector encoding mCherry-LC3 utilizing the X-tremeGENE™ HP DNA 
transfection reagent (Sigma-Aldrich) according to the manufacturer’s instructions. A day 
later, the medium was changed and the next day treatments were performed as described 
above. Subsequently, cells were washed twice with PBS and fixed for 10 min with 4% 
paraformaldehyde in PBS at 4°C. Cells were extensively washed with PBS and stored in PBS 
at 4°C until imaged. Confocal images were taken utilizing a 63x objective on a Zeiss 
LSM510 microscope (Jena, Germany). The amount of mCherry-LC3 puncta in each cell were 
calculated utilizing the WatershedCounting3D plug-in for ImageJ. (36) 
 
2.5 Outer ER membrane-targeted Ca
2+
 measurements 
 
The genetically encoded outer ER membrane-targeted (OER) Ca
2+
 indicator OER-GCaMP6f 
was expressed in HEK RyR3 cells under the control of the cytomegalovirus promoter (37). 
HEK RyR3 cells were seeded in round four-chamber slides, and after 24 hours, transfected 
with the OER-GCaMP6f probe using the X-tremeGENE™ HP DNA transfection reagent 
according to the manufacturer’s instructions. The medium was changed the next day, and the 
following morning cells were treated as described in section 2.2. After the 3 hours treatment, 
the medium was replaced with a modified Krebs solution (135 mM NaCl, 6.2 mM KCl, 1.2 
mM MgCl2, 12 mM HEPES, pH 7.3, 11.5 mM glucose and 2 mM CaCl2) supplemented with 
either DMSO, 10 µM dantrolene or 20 µM ryanodine before starting the Ca
2+
 measurements. 
  
Single-cell Ca
2+
 measurements were performed in OER-GCaMP6f-positive cells using a 
Zeiss Axio Observer Z1 Inverted Microscope equipped with a 20x air objective and a high-
speed digital camera (Axiocam Hsm, Zeiss, Jena, Germany). Images were taken at 5 hertz. 
Spontaneous peri-ER Ca
2+
-release events were measured for 300 sec. Using an automated 
perfusion system, the RyR agonist caffeine was subsequently added at a concentration of 1.5 
mM (for 120 sec) and 10 mM (for 70 sec).  
 
2.6 Transmission electron microscopy 
 
C2C12 cells were cultured, differentiated for 5 days and treated as stated in section 2.2. After 
the 3 hours treatments, the cells were trypsinized (Thermo Fisher Scientific), collected and 
pelleted at 500 x g. The pellets were washed once with PBS prior to fixation in 0.1 M sodium 
cacodylate-buffered (pH 7.4) 2.5% glutaraldehyde solution. Further handling of the samples 
and transmission electron microscopy (TEM) was performed as described. (38)  
 
2.7 Statistical analysis 
 
Sample size and normalization of data are indicated in the figure legends. When three groups 
were compared an ANOVA with Dunnett’s multiple comparison post hoc test was 
performed. When two groups were compared a two-tailed unpaired or paired student’s t-test 
was used. Differences between groups were considered significant (*) when P<0.05 (P values 
  
for the ANOVA and student’s t-test are given in the figures). ** and *** indicate P values 
<0.01 and <0.001, respectively. The exact P values are provided, unless P <0.0001.  
  
  
3. Results  
 
3.1 Inhibition of ectopically expressed RyR3 in HEK293 cells stimulates autophagic flux 
 
In order to determine the potential effects of the RyR on autophagy and to decipher the 
autophagic pathway involved, we used HEK293 cells stably expressing the RyR3 channel 
(HEK RyR3). RyR protein levels were detected via immunoblot using a RyR antibody that 
recognizes all RyR isoforms (Figure 1A). A strong RyR expression was observed in HEK 
RyR3 cells whereas no RyR expression was detected in HEK293 cells expressing the empty 
vector (HEK control). Autophagy was monitored using the marker LC3-II, the lipidated form 
of LC3-I, which is incorporated into the autophagosomes. Overexpression of RyR3 resulted 
in increased levels of LC3-II compared to the HEK control cells (Figure 1A). To further 
document the contribution of RyRs in regulating autophagy, HEK RyR3 cells were treated 
for three hours with two RyR inhibitors: dantrolene (10 µM) or a high dose of ryanodine (20 
µM). Both dantrolene and ryanodine treatments reduced LC3-II levels compared to the 
vehicle control (Figure 1B) in HEK RyR3 cells. This indicates that the increase in LC3-II 
upon is due to RyR3 overexpression as this can be counteracted by RyR inhibitors. Two 
possibilities exist for the decline in LC3-II levels upon RyR inhibition.(31) RyR inhibition 
might lead to a decrease in autophagic flux, particularly in the steps preceding LC3-II and 
autophagosome formation. Alternatively, RyR inhibition might lead to an increased clearance 
of LC3-II and autophagosomes due to fusion with the lysosomes, corresponding to an 
increased autophagic flux. To further document this we used the RyR inhibitors in the 
presence of the lysosomal inhibitor bafilomycin A1, which was added during the last hour of 
the treatments. Neither dantrolene nor ryanodine diminished the amount of LC3-II that 
  
accumulated in cells incubated with bafilomycin A1. Bafilomycin A1 halts autophagic flux at 
the step of autophagosomal and lysosomal fusion. These data therefore suggest that 
dantrolene and ryanodine decrease LC3-II, not by preventing its formation, but by increasing 
its degradation at a step distal to autophagosomal and lysosomal fusion (Figure 1B). This 
indicates that the observed decrease in LC3-II protein levels upon RyR inhibition is due to an 
increased clearance of LC3-II by lysosomal degradation, and thus an increased autophagic 
flux. 
Hence, these results indicate that RyR3 inhibition increases LC3-II breakdown in the 
autolysosomes. An increase in the number of autolysosomes upon RyR inhibition could 
account for these observations. We therefore assessed the number of mCherry-LC3 puncta in 
HEK RyR3 cells exposed to the vehicle, dantrolene, or ryanodine. We opted to use mCherry-
LC3 puncta, because mCherry, in contrast to green fluorescent protein (GFP), is not 
quenched by acidification of the lysosomes. As a consequence, mCherry-LC3 allows 
quantification of the total number of autophagosomes and autolysomes without using 
bafilomycin A1, which also affects Ca
2+
 homeostasis at the lysosomes.(39) Moreover, HEK 
RyR3 cells displayed a prominent autofluorescence upon excitation at 480 nm, thereby 
hampering the use of GFP-LC3 for quantitative puncta determination. Figure 1C (left panel) 
shows an example of HEK RyR3 cells transiently transfected with mCherry-LC3 and treated 
for three hours with the vehicle or the indicated amounts of dantrolene or ryanodine. 
Quantification of the total number of mCherry-puncta per cell for each condition (Figure 1C, 
right panel) revealed that RyR3 inhibition increased the number of mCherry-LC3 puncta and 
thus the number of autophagosomes and autolysosomes. 
 
 
  
3.2 RyR3 inhibition does not alter the proximal/intermediate steps of autophagy 
 
Using mCherry-LC3, it is not possible to determine whether the observed increase in 
mCherry-LC3 punctae is due to an increase in autophagosomes, autolysosomes or a 
combination of the two. In order to elucidate these aspects in more detail, we examined 
different autophagy markers in HEK RyR3 cells treated with dantrolene or ryanodine (Figure 
2). We studied markers involved in the initiation of the autophagic pathway (e.g. AMPK and 
mechanistic target of rapamycin (mTOR) activity).(31)  AMPK activity (assessed via its 
phosphorylation state) and mTOR activity (assessed via the phosphorylation of S6 ribosomal 
protein (S6RP) a downstream target of mTOR) were not altered upon treatment of cells with 
dantrolene or ryanodine. This indicated that RyR inhibition in these cells did not impair 
mitochondrial bio-energetics or nutrient-sensing mechanisms. Also, total Beclin 1 levels, a 
protein involved in the early events of autophagosome formation, were not affected by 
dantrolene or ryanodine. Combining this information with the data from section 3.1 indicates 
that RyR inhibition appears to enhance the turn-over of autophagosomal cargo without 
affecting the earlier steps of autophagy involved in the production and formation of 
autophagosomes.  
 
3.3 Dantrolene and ryanodine inhibit spontaneous RyR3-mediated Ca
2+
 release in the 
conditions used for analyzing autophagic flux 
 
As the impact of the RyR inhibitors on basal autophagic flux was determined in the absence 
of RyR agonist, we aimed to determine whether these inhibitors were able to suppress 
  
spontaneous RyR-mediated Ca
2+
 release in exactly the same conditions used for determining 
their impact on autophagic flux. We therefore used a recently developed genetically encoded 
Ca
2+
 indicator (GECI), based on GCaMP6f, which is targeted to the outer side of the ER 
membrane (OER-GCaMP6f). (37) This GECI is able to detect small Ca
2+
-release events at 
subcellular resolution in the close proximity of the ER membrane. We previously showed that 
spontaneous RyR3-mediated Ca
2+
-release events occur in HEK RyR3 cells. (40) Here, we set 
out to assess whether dantrolene and ryanodine could inhibit these spontaneous events under 
conditions used for measuring their impact on autophagy. Spontaneous peri-ER Ca
2+
-release 
events were measured in OER-GCaMP6f-transfected HEK RyR3 cells (Figure 3). Images 
were taken at 5 hertz, enabling a sufficiently high time resolution to also register small RyR-
mediated-Ca
2+
 release events. In order to be classified as a bona fide spontaneous Ca
2+
-
release event, we established that the maximum peak amplitude of the Ca
2+
 release should be 
at least 0.02 units above baseline and/or should form a Ca
2+
 transient lasting longer than 5 
secs. Figure 3A shows a typical experiment. OER-GCaMP6f-transfected HEK RyR3 cells 
were treated for three hours with DMSO, dantrolene (10 µM) or ryanodine (20 µM) before 
measuring spontaneous Ca
2+
 release. With regard to the DMSO-treated HEK RyR3 cells, 
41,14% ± 2.12 showed spontaneous activity within a time frame of 5 minutes. A three hour 
treatment with dantrolene or ryanodine, strongly reduced the proportion of spontaneously 
active cells to 18.70% ± 2.25 and 9.74% ± 2.67 respectively (Figure 3A and B ). In order to 
show the presence of functional RyR3, the cells were subsequently treated with caffeine. 
DMSO- and dantrolene-treated cells responded to 1.5 mM caffeine with a pronounced RyR-
mediated Ca
2+
 release. In the ryanodine-treated cells, however, even a 10 mM dose of 
caffeine only triggered a small RyR-mediated Ca
2+
 release. Hence, dantrolene and ryanodine 
efficiently inhibited spontaneous RyR-mediated Ca
2+
 release in the HEK RyR3 cells under 
conditions in which both inhibitors were able to augment autophagic flux. 
  
3.4 Dantrolene stimulates autophagic flux in differentiated C2C12 cells 
 
The HEK RyR3 cells are a robust and tractable cellular model to study the effects of RyR 
overexpression on autophagy. However, overexpressing RyRs in cells that do not 
endogenously express this channel may lead to severe alterations in cellular processes 
without major physiological relevance. Therefore, we performed experiments in 
differentiated C2C12 cells and primary dissociated hippocampal neurons, both expressing 
RyRs endogenously. Since dantrolene and ryanodine treatments produced similar results, and 
dantrolene is in clinical use, we decided to continue these experiments with dantrolene. 
Undifferentiated/proliferating C2C12 myoblasts do not display endogenous RyR expression. 
However, upon differentiation into myotubes, these cells express large amounts of RyR1, 
allowing to determine the effects of inhibiting endogenous RyR channels on autophagy in a 
physiologically relevant cell model. Similar experiments as in the HEK RyR3 cells were 
performed. Undifferentiated and 5-days differentiated C2C12 cells were treated with 
dantrolene for three hours, after which autophagic markers were assessed (Figure 4 A). After 
5 days of differentiation, RyR expression could be detected (Figure 4A, top). Similarly as in 
HEK RyR3 cells, dantrolene treatment resulted in a decrease in LC3-II levels in differentiated 
C2C12 cells, but not in undifferentiated/proliferating C2C12 cells. This not only confirms our 
previous findings obtained in HEK RyR cells but also indicates that the effects of dantrolene 
on autophagy are mediated through RyR inhibition. Similarly to our results obtained with 
HEK RyR cells (Figure 1), dantrolene was not able to provoke a decrease in LC3-II levels if 
the C2C12 cells were exposed to bafilomycin A1. Moreover, dantrolene treatment of the 5-
days differentiated C2C12 cells did not affect the activity/level of several proximal 
autophagic markers like phosphorylated AMPK, mTOR-substrate S6RP phosphorylation and 
total Beclin 1 levels (Figure 4B). Because of difficulties in combining cellular differentiation 
  
with efficient overexpression of constructs to monitor autophagy in C2C12 cells, we 
performed TEM as an additional technique (Figure 4C). C2C12 cells were differentiated for 5 
days and then treated similarly as above with dantrolene for three hours before preparing the 
samples for TEM. The number of early autophagic vacuoles, vacuolar structures clearly 
containing cellular components delineated by a double membrane (white arrows in Figure 
4C), were determined. This TEM analysis revealed that the DMSO-treated cells contained 
significantly more early autophagic vacuoles per cellular cross-section compared to the 
dantrolene-treated cells (5.9 ± 2.97 to 1.8 ± 1.03 early autophagic vacuoles per cellular cross-
section respectively). These experiments suggest that the presence of functional RyR 
channels results in the accumulation of early autophagic vacuoles, which can be cleared by 
RyR inhibition. Thus, these results are fully compatible with an increase in autophagic flux 
due to a stimulation of autophagosome clearance via the lysosomes upon inhibition of basal 
RyR activity. 
 
3.5 RyR inhibition stimulates autophagic flux in dissociated hippocampal neurons 
 
Finally, we aimed to determine the effect of dantrolene on autophagy in primary dissociated 
hippocampal neurons, given the previous use of dantrolene in models for neurodegeneration. 
Therefore, rat hippocampi were harvested at embryonic day 18 from which neurons were 
cultured. Fifteen days later, the resulting neurons were treated with dantrolene for three hours 
and autophagy was monitored using the LC3-II marker (Figure 5). Treating hippocampal 
neurons with dantrolene (10 or 20 µM) showed a decrease in the amount of LC3-II protein 
which was abolished when bafilomycin A1 was added during the last hour of the treatments. 
This suggests that also in the hippocampal neurons, RyR inhibition leads to an increased 
  
clearance of LC3-II from the autophagosomes by lysosomal degradation, confirming that 
dantrolene treatment accelerates the autophagic flux. 
  
  
4. Discussion 
 
The major finding of this study is that basal, spontaneous RyR activity suppresses autophagic 
flux by reducing autophagosomal-lysosomal turnover. Application of RyR inhibitors to cell 
models that ectopically or endogenously express RyRs results in a decrease in LC3-II that 
could be attributed to an increase in autophagosomal-lysosomal turnover. Thus, chemical 
inhibition of RyRs can boost autophagic flux and clearance of autophagosomal cargo in the 
lysosomes in a variety of RyR-expressing cell systems.  
 
Currently, the regulation of autophagosomal-lysosomal fusion events by intracellular Ca
2+
 
remains poorly understood. An interesting hypothesis for this regulation is based on intimate 
connections existing between lysosomes and the ER in general, but also with the RyRs in 
particular. (3,41-43) RyRs that are in close proximity to lysosomes can be activated by Ca
2+
 -
induced Ca
2+
 release, triggered by small Ca
2+
 releases from the lysosomes thereby leading to 
an amplification of the signal. (44) Although Ca
2+
 is involved in lysosomal fusion events, 
excessive Ca
2+
 levels could hamper this process. For instance, it was reported that after TPC2 
overexpression, TPC2-mediated lysosomal Ca
2+
 release impaired autophagosomal/lysosomal 
turnover. (13,14) These lysosomal Ca
2+
 releases could trigger RyR activation thereby 
amplifying the Ca
2+
 signal which in turn could hamper the fusion of autophagosomes with 
lysosomes and prevent the degradation of autophagosomal cargo. The single-cell Ca
2+
 
measurements performed in section 3.3 showed that inhibiting RyR3 activity reduced 
spontaneous ER Ca
2+
 release. Combining these Ca
2+
 measurements with the observed 
increased autophagic flux in these and the other tested cells (sections 3.1, 3.4 and 3.5) 
  
induced by RyR inhibition suggests a role for basal RyR-mediated Ca
2+
 release in the 
regulation of autophagosomal clearance via the lysosomes. 
 
Combining our findings on RyRs with the previous work from the Foskett lab on IP3Rs (8), it 
seems that the spontaneous activity of both types of intracellular Ca
2+
-release channels can 
suppress autophagic flux. While IP3Rs act at the mitochondrial level by increasing 
mitochondrial bio-energetics and thus ATP output, resulting in a decline of AMPK activity, a 
positive regulator of autophagy (8), RyRs likely act more distal in the autophagy process at 
the level of the lysosomes by suppressing the clearance of autophagosomes. At this time we 
cannot fully exclude that RyR activity may also affect earlier steps in the autophagy process 
via influencing other parameters/targets beyond the scope of this study. In any case, our new 
findings further support the relevance of Ca
2+
 microdomains in the regulation of cellular 
processes like autophagy. (3) 
 
Our findings might also be of importance to understand the contribution of dysregulated RyR 
expression and function for the pathogenesis of AD. During AD, lysosomal functioning is 
hampered, resulting in a reduced clearance of autophagosomal cargo at the lysosomes.(45,46) 
At the same time, increased levels of RyR3 as well as excessive RyR-mediated Ca
2+
 release 
have been shown to be early/intermediate events in AD pathogenesis in several models. 
(19,23-25,47) Blocking RyRs utilizing dantrolene has been reported to have beneficial effects 
in these mouse models by reducing pathological protein aggregates and memory impairment. 
(23-25) However, it should be noted that in contrast to the beneficial effects in AD mouse 
models, prolonged feeding of dantrolene to AD mice was also linked to an increased amyloid 
load. (48)  Differences in the amounts, administration, mouse models and duration of the 
  
dantrolene treatments have been mentioned as potential underlying explanations for these 
discrepancies.(47,49) The findings described in this paper would fit with a beneficial effect of 
RyR inhibition on AD progression. A decreased autophagic flux was seen upon 
overexpression of RyR3 in HEK293 cells. This could be reversed by inhibiting the RyR with 
dantrolene (section 3.1). These findings were confirmed in primary dissociated hippocampal 
neurons indicating that a similar regulation of autophagic flux occurs in neurons (section 3.4). 
Stimulation of autophagic flux via RyR inhibition may thus in part account for the beneficial 
effects described for dantrolene in AD.(23-25) However, more research will be necessary to 
investigate this further. In addition, it is currently unknown how prolonged RyR inhibition 
would impact the autophagic process. It will therefore be interesting and necessary to study 
the effects of long- term dantrolene feeding on autophagy in neurons. 
 
Finally, our results further highlight the importance of performing autophagic flux 
experiments using lysosomal inhibitors and performing independent approaches to 
adequately interpret altered LC3-II levels in terms of autophagy. Indeed, cells overexpressing 
RyR3 display increased LC3-II levels compared to control counterparts, which actually is due 
to an inhibition of autophagic flux at a distal step instead of an induction of autophagy. 
In conclusion, we show that overexpression of RyR3 elevates LC3-II levels. This could be 
attributed to a decreased clearance of autophagosomes as acute inhibition of RyR3 increased 
the autophagic flux by promoting the turn-over of autophagosomal cargo at the level of the 
lysosomes. These findings were confirmed in differentiated C2C12 cells and dissociated 
hippocampal neurons, both expressing endogenous RyRs. Hence, this indicates that 
spontaneous Ca
2+
-release events mediated by RyR channels may negatively regulate the 
autophagy process at the lysosomes.  
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Figure legends 
 
Figure 1: Inhibition of ectopically expressed RyR3 in HEK293 cells stimulates 
autophagic flux. 
 
(A) Left, immunoblot comparing HEK control cells to HEK RyR3 cells stained for the RyR, 
GAPDH and LC3. The used LC3-antibody recognizes both LC3-I (top band) and LC3-II 
(lower band).  Right, quantification of the LC3-II levels obtained from different experiments. 
The averages ± SD (n=5) are shown relative to the HEK control cells. Each data point 
represents an independently performed experiment. (B) Left, Immunoblot of HEK RyR3 cells 
treated for three hours with the vehicle (DMSO), 10 µM dantrolene or 20 µM ryanodine 
stained for the RyR, actin and LC3. When indicated bafilomycin A1 (100 nM) was added 
during the last hour of the treatment. Equal amounts of the vehicle (DMSO) were added to all 
samples. Right, quantification of LC3-II levels from the performed experiments in HEK 
RyR3 cells in the presence or absence of bafilomycin A1. Averages ± SD (n≥10) are shown 
relative to the vehicle control obtained in each experiment. Each data point represents an 
independently performed experiment. (C) Left, Z-projection of confocal image stack showing 
HEK RyR3 cells expressing mCherry-LC3 after the indicated treatments. Right, 
Quantification of mCherry-LC3 puncta, the average (± SEM) of five independently 
performed experiments is shown. Each data point represents the average of at least 10 cells.  
 
 
 
  
Figure 2: RyR3 inhibition does not alter the proximal/intermediate steps of autophagy 
 
Left, Immunoblots of lysates obtained from HEK RyR3 cells treated for three hours with the 
indicated RyR inhibitors or the vehicle control. Immunostaining was performed for 
proximal/intermediate autophagic markers. The antibodies used are indicated for each 
immunoblot. Right, Quantification of the performed experiments. Each data point represents 
an independently performed experiment. Averages ± SD (n≥5) are shown relative to the 
DMSO control treatment.  
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3: Dantrolene and ryanodine inhibit spontaneous RyR3-mediated Ca
2+
 release in 
the conditions used for analyzing autophagic flux 
 
Single-cell Ca
2+
 measurements performed on OER-GCaMP6f-transfected HEK RyR3 cells. 
A) Top, typical example of single-cell Ca
2+
 measurements performed after transfection with 
OER-GCaMP6f. Cells were treated for three hours with DMSO, dantrolene (10 µM) or 
ryanodine (20 µM) before starting the measurements. Spontaneous activity was measured in 
Krebs solution containing the indicated additions. In order to be classified as a bona fide 
spontaneous Ca
2+
-release event, we established that the maximum peak amplitude of the Ca
2+
 
release should be at least 0.02 units above baseline and/or should form a Ca
2+
 transient lasting 
longer than 5 secs. After measuring spontaneous activity for 5 min, RyRs were subsequently 
stimulated with 1.5 mM and 10 mM caffeine. Bottom, magnification of top panel 
highlighting showing spontaneous active cell during the first 5 minutes. B) Quantification of 
the performed experiments. The % of spontaneously active cells (grey part of the bar) was 
determined for each condition. Values indicate averages ± SEM of three independently 
performed experiments (at least 150 cells were measured/condition).  
 
 
 
 
 
 
  
Figure 4: Dantrolene stimulates autophagic flux in differentiated C2C12 cells 
 
A) Left, immunoblot of undifferentiated (0 days) and differentiated (5 days) C2C12 cells 
treated for 3 hours with 10 µM of dantrolene in the presence or absence of bafilomycin A1 
(100 nM) during the last hour. Immunostainings were performed for LC3, RyR and GAPDH. 
Right, quantification of LC3-II levels in the performed experiments in the presence or 
absence of bafilomycin A1 (100 nM). Each data point represents an independently performed 
experiment. Averages ± SD (n≥8) are shown relative to LC3-II levels in the control 
treatment. B) Top, immunoblots for proximal/intermediate autophagic markers in C2C12 
cells differentiated for 5 days treated for 3 hours with 10 µM of dantrolene. Bottom, 
quantification of the performed experiments. Averages ± SD (n≥3) are shown relative to the 
control treatment. Each data point represents an independently performed experiment. C) 
Left, representative TEM images showing C2C12 cells differentiated for 5 days and treated 
for three hours as indicated. The white arrows indicate early autophagosomal vacuoles (scale 
bar: 500 nm). Right, quantification of the number of early autophagic vacuoles per cellular 
cross-section. Values indicate average ± SD. The number of early autophagosomal vacuoles 
was counted in 10 randomly chosen cells per condition.  
 
 
 
 
 
  
Figure 5: RyR inhibition stimulates autophagic flux in dissociated hippocampal neurons 
 
Left, Immunoblot showing LC3 levels in lysates of 15 day-old dissociated hippocampal 
neurons treated for 3 hours with 10 or 20 µM dantrolene. When indicated bafilomycin A1 
(100 nM) was added during the last hour of the treatments. Right, Quantification of the LC3-
II levels from the performed experiments in the presence or absence of bafilomycin A1. For 
each independently performed experiment (each date point), a new set of hippocampal 
neurons was isolated. Averages ± SD (n=4) are shown relative to the control treatment. 
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